![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessA novel pleural-bladder pump for the management of recurrent malignant pleural effusions: a feasibility animal study
Recurrent malignant pleural effusions (MPE) are common and associated with significant morbidity in cancer patients. A new pump connecting the pleural cavity and the bladder may have application for the manage...
-
Article
Open AccessPositive thyroid transcription factor 1 staining strongly correlates with survival of patients with adenocarcinoma of the lung
This study investigated the relation between positive thyroid transcription factor 1 (TTF1) staining and survival of patients affected by primary adenocarcinoma (ADC) of the lung. Pathological tissue from cons...
-
Article
Open AccessCYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) as gefitinib emerged as an accepted treatment in second- or third-line setting in NSCLC. However, clinical surrogate markers of EGFR-TKI...
-
Article
Open AccessSummary report of the Standards, Options and Recommendations for the management of patients with non-small-cell lung carcinoma (2000)